Turnover
≈ €260,000 estimated
The micro format states no turnover.
AnesTHeezy
Lifetime
1 annual account with figurespeak €137,976 (2025)
€137,976
peak €96,274 (2025)
€96,274
peak €99,274 (2025)
€99,274
€57,554
Board1 name since 2024
1 directorTRUONG Hà-Nam
Documentsfilings and deeds
14-08-202614 days late
2025micro format
1 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€3,000 100 shares
2025 accounts filed 14 days after the deadline
Checked score
95
Excellent
Financially stronger than 61% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2025: 0.3%
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.4%▲ +0.1 percentage points vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.4%● unchanged vs 07-2026highest value
09-2026: < 0.1%▼ -0.4 percentage points vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.97, cash €41,257
Figures for financial year 2025 (filed on 14-08-2026)
Equity €99,274 (63.3% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 51% of them on solvency, 53% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as AnesTHeezy has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of AnesTHeezy itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for AnesTHeezy. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 2.97, above the usual 1.5. Short-term debt is 27.7% and cash 26.3% of total assets. 36.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Young company
Founded in 2024, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
raises risk · 2025 accounts filed 14 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
14 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1016779239
First establishment
Rode Beukenlaan 29, Wezembeek-Oppem
Incorporation
Founding capital of €3,000, 100 shares · Founder: TRUONG Hà-Nam · Appointment: TRUONG Hà-Nam (director) · published on 03-12-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| AnesTHeezy Wezembeek-Oppem | €156,828 | €137,976 | 63.3% | - |
| Epple Leuven | €146,777 | €133,271 | 90.5% | - |
| Medstrazdas Wemmel | €140,724 | €134,276 | 74.5% | - |
| IZI CAPITAL Vilvoorde | €151,565 | €149,812 | 77.3% | - |
| COLORAD Leuven | €175,886 | €152,889 | 63.7% | - |
| DOKTER DIRK VAN GYSEL Roosdaal | €133,205 | €142,107 | 74.8% | - |
| Norma MD Kortrijk | €160,241 | €138,093 | 68.3% | - |
These companies have the same main activity as AnesTHeezy: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €133,000 and €176,000, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 29-11-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.366.818.1131970 Wezembeek-Oppem, since 01-01-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 11-12-2025
Insights on AnesTHeezy
AnesTHeezy has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €99,274 and a net result of €96,274.
Its solvency ranks better than 50% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about AnesTHeezy
- What is the company number of AnesTHeezy?
- The company number of AnesTHeezy is 1016.779.239. The VAT number is the same number with BE in front: BE 1016.779.239.
- Where is AnesTHeezy based?
- The registered office is at Rode Beukenlaan 29, 1970 Wezembeek-Oppem.Company details
- What does AnesTHeezy do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of AnesTHeezy?
- AnesTHeezy is a private limited company (BV).
- When was AnesTHeezy founded?
- AnesTHeezy was founded on 29-11-2024.
- Is AnesTHeezy still active?
- Yes, AnesTHeezy is an active enterprise in the KBO register.
- What is the turnover of AnesTHeezy?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €137,976 and 41 comparable companies (NACE 86220). It probably lies between €220,000 and €340,000.Financials
- Is AnesTHeezy profitable?
- In financial year 2025, AnesTHeezy made a profit of €96,274.
- Where can I find the annual accounts of AnesTHeezy?
- AnesTHeezy filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.